Neuphoria Therapeutics Inc 6-K, filed Jan 9, 2023
Neuphoria Therapeutics Inc. (NEUP)
About this 6-K
Neuphoria Therapeutics Inc filed this 6-K on January 9, 2023.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of January, 2023
(Commission File No. 001-41157)
BIONOMICS LIMITED
(Translation of registrant’s name into English)
200 Greenhill Road
Eastwood SA 5063
Tel: +618 8150 7400
(Address of registrant’s principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1):
Yes ☐ No ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7):
Yes ☐ No ☐
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K
On January 09, 2023, the Company lodged a Notification of Director's Initial Interest for Spyros Papapetropoulos on Appendix 3X, and a Notification of Cessation of Securities in relation to the expiry of unlisted options under the Company's employee incentive plan on Appendix 3H, with the Australian Securities Exchange (ASX) as required by the laws and regulations of Australia, to disclose a change in interests in securities and contracts with the Company. The notifications are furnished herewith as Exhibits 99.1 and 99.2 to this report on Form 6-K.
1
EXHIBIT INDEX
|
|
Exhibit
|
Description
|
99.1 |
|
99.2 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
|
|
|
|
Bionomics Limited |
|
|
(Registrant) |
|
|
|
|
|
By: |
/s/ Errol De Souza
|
|
Name: |
Errol De Souza, Ph.D. |
|
Title: |
Non-Executive Chairman |
Date: January 09, 2023
1
Exhibit 99.1
Rule 3.19A.1
Appendix 3X
Initial Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity BIONOMICS LIMITED |
ABN 075 582 740 |
We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director |
Spyridon Papapetropoulos |
Date of appointment |
5 January 2023 |
Part 1 - Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
Nil
|
+ See chapter 19 for defined terms.
11/3/2002 Appendix 3X Page 1
Appendix 3X
Initial Director’s Interest Notice
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest.
|
Number & class of Securities
Nil |
Part 3 – Director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract |
N/A |
Nature of interest
|
N/A |
Name of registered holder (if issued securities)
|
N/A |
No. and class of securities to which interest relates
|
N/A |
+ See chapter 19 for defined terms.
Appendix 3X Page 2 11/3/2002
Exhibit 99.2
|
Notification of cessation of +securities |
Announcement Summary
Entity name
BIONOMICS LIMITED
Announcement Type
New announcement
Date of this announcement
Monday January 09, 2023
Details of +securities that have ceased
Number of
ASX +security +securities that The +securities have Date of
code Security description have ceased ceased due to cessation
BNOAO OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES BNOAO OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES BNOAO OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES BNOAO OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES BNOAO OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES |
200,000 Expiry of option or other convertible security without exercise or conversion 4,000 Expiry of option or other convertible security without exercise or conversion 5,000 Expiry of option or other convertible security without exercise or conversion 100,000 Expiry of option or other convertible security without exercise or conversion 50,000 Expiry of option or other convertible security without exercise or conversion |
11/12/2022 |
Refer to next page for full details of the announcement
Exhibit 99.2
Notification of cessation of +securities 1 / 6
Exhibit 99.2
|
Notification of cessation of +securities |
Part 1 - Announcement Details
1.1 Name of +Entity
BIONOMICS LIMITED
We (the entity named above) provide the following information about our issued capital.
1.2 Registered Number Type ABN
1.3 ASX issuer code BNO
1.4 The announcement is
New announcement
Registration Number
53075582740
1.5 Date of this announcement 9/1/2023
Notification of cessation of +securities 2 / 6
Exhibit 99.2
|
Notification of cessation of +securities |
Part 2 - Details of +equity securities or +debt securities that have ceased
ASX +Security Code and Description
BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Unquoted +equity securities that have ceased
Number of securities that have ceased
200,000
Reason for cessation
Expiry of option or other convertible security without exercise or conversion
Date of cessation
11/12/2022
Is the entity paying any consideration for the cessation?
No
Any other information the entity wishes to notify to ASX about the cessation?
Expiry of options under employee incentive scheme to non-KMP members
ASX +Security Code and Description
BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Unquoted +equity securities that have ceased
Number of securities that have ceased
4,000
Reason for cessation
Expiry of option or other convertible security without exercise or conversion
Date of cessation
17/12/2022
Is the entity paying any consideration for the cessation?
No
Any other information the entity wishes to notify to ASX about the cessation?
Expiry of options under employee incentive scheme to non-KMP members
ASX +Security Code and Description
BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Unquoted +equity securities that have ceased
Number of securities that have ceased
5,000
Notification of cessation of +securities 3 / 6
Exhibit 99.2
Notification of cessation of +securities
Reason for cessation
Expiry of option or other convertible security without exercise or conversion
Date of cessation
18/12/2022
Is the entity paying any consideration for the cessation?
No
Any other information the entity wishes to notify to ASX about the cessation?
Expiry of options under employee incentive scheme to non-KMP members
ASX +Security Code and Description
BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Unquoted +equity securities that have ceased
Number of securities that have ceased
100,000
Reason for cessation
Expiry of option or other convertible security without exercise or conversion
Any other information the entity wishes to notify to ASX about the cessation?
Expiry of options under employee incentive scheme to non-KMP members
ASX +Security Code and Description
BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES
Unquoted +equity securities that have ceased
Number of securities that have ceased
50,000
Reason for cessation
Expiry of option or other convertible security without exercise or conversion
Date of cessation
24/12/2022
Is the entity paying any consideration for the cessation?
No
Date of cessation
30/12/2022
Is the entity paying any consideration for the cessation?
No
Any other information the entity wishes to notify to ASX about the cessation?
Expiry of options under employee incentive scheme to non-KMP members
Notification of cessation of +securities 4 / 6
Exhibit 99.2
|
Notification of cessation of +securities |
Notification of cessation of +securities 5 / 6
Exhibit 99.2
|
Notification of cessation of +securities |
Part 3 - Issued capital following changes
Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:
3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
Total number of
ASX +security code and description +securities on issue
BNO : ORDINARY FULLY PAID 1,468,735,424
3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
Total number of
ASX +security code and description +securities on issue
BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 85,689,567
BNOAS : WARRANTS 142,000,000
Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.
Notification of cessation of +securities 6 / 6